First Citizens Bank & Trust 13F: Adds $8.1M to LLY Stake

First Citizens Bank & Trust significantly increased its stake in Eli Lilly and Company (NYSE:LLY) as revealed in its latest 13F filing with the SEC. The bank boosted its holdings by 7,019 shares, a 22.3% increase, bringing its total to 38,512 shares valued at approximately $44.6 million. This filing reflects the bank's holdings as of the end of the reporting period and may not represent its current position.

What Changed in First Citizens Bank & Trust's Eli Lilly Position

First Citizens Bank & Trust increased its investment in Eli Lilly by 7,019 shares, growing its stake by 22.3% from 31,493 to 38,512 shares. The total value of this position is now about $44.6 million.

Eli Lilly and Company Stock Up 3.8%

Shares of Eli Lilly (NYSE:LLY) were last reported with a market capitalization of approximately $1.12 trillion. The company has a P/E ratio of 42.0 and a forward P/E of 26.4, indicating investor expectations for future earnings growth. Eli Lilly's stock has traded between $783.85 and $1,292.65 over the past 52 weeks. Its 50-day moving average is around $1,179.04, while the 200-day moving average stands at $1,079.02. The company's beta is 0.453, suggesting it is less volatile than the broader market.

Recent Earnings

Eli Lilly reported revenue of approximately $79.67 billion, reflecting a growth of 47.7%. The company achieved a net margin of 33.5% and a return on equity of 102.3%. Its next earnings release is scheduled for October 29, 2026.

Dividend

Eli Lilly offers an annual dividend yield of 0.55%, with a payout ratio of 21.69%. This reflects the company's commitment to returning value to shareholders while maintaining a sustainable payout.

About Eli Lilly and Company

Eli Lilly and Company, headquartered in Indianapolis, Indiana, is a global healthcare leader in the pharmaceutical industry. Founded in 1876, the company discovers, develops, and markets a wide range of pharmaceutical products, including treatments for diabetes, oncology, and immunology. Under the leadership of CEO Mr. David A. Ricks, Eli Lilly employs around 50,000 people worldwide and continues to innovate in the healthcare sector.

Bottom Line

First Citizens Bank & Trust's decision to increase its stake in Eli Lilly by 22.3% underscores its confidence in the company's potential. Investors closely watch 13F filings to gauge institutional sentiment, though these filings are backward-looking and might not reflect current positions. Eli Lilly's strong market presence and financial performance continue to make it a key player in the healthcare industry.